Intravitreal ganciclovir implantation is an effective treatment for cytomegalovirus retinitis. An implant recently has been approved by the Food and Drug Administration and is commercially available. Because implantation eliminates the need for an indwelling catheter and offers an improved quality of life, it may become a more popular initial treatment for cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome.
As with all intraocular procedures, complications can occur. We report one case in which the placement of an intravitreal ganciclovir implant was complicated by the formation of cyclodialysis. This necessitated the repositioning of the implant to a different quadrant. Despite gonioscopic evidence of the cyclodialysis cleft, the eye remained normotensive postoperatively.
Report of a Case.
A 45-year-old phakic man with acquired immunodeficiency syndrome and bilateral cytomegalovirus retinitis elected to undergo insertion of an intravitreal ganciclovir implant in his right eye. He had previously undergone uncomplicated placement of an intravitreal
Gentile RC, Lewis JM, Puklin JE. Cyclodialysis Complicating Intravitreal Ganciclovir Implantation. Arch Ophthalmol. 1997;115(9):1204-1205. doi:10.1001/archopht.1997.01100160374023